Antitumor and cytogenetic effects of esteric (ASE) and amidic (ASA) steroidal derivative of p-bis (2-chloroethyl) amino phenylacetic acid (CAPA). A comparative study

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4525-4529

  Nikolaropoulos, Sotiris S ^a   Arsenou, Evagelia S ^a   Papageorgiou, Athanasios ^b   Mourelatos, Dionisis ^c  

^a UNIVERSITY OF PATRAS   (Greece)

^b Lab of Experimental Chemotherapy TheagenionMedicalInstitute   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Antileukemic effects; Antitumor steroidal derivatives; ASA; ASE; CAPA; Cytogenetic effects; Nitrogen mustards

Indexed keywords

PHENYLACETIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOGENETICS; CYTOSTASIS; DNA SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMIA P 388; MOUSE; NONHUMAN; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

EID: 0031409791     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wall ME, Abernethy GS Jr, Caroll FJ and Taylor DJ: The effect of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems. J Med Chem 12: 810-818, 1969.
2. Wampler GL and Catsoulacos P: Antileukemic effect of homo-azasteroidal ester of p-bis (2-chloroethyl)-aminophenylacetic acid. Cancer Treat Rep 61: 37-41, 1977.
3. Catsoulacos P, Politis D and Wampler GL: A new steroidal alkylating agent with improved activity in advanced murine leukemias. Cancer Chemother. Pharmacol 3: 67-70, 1979
4. Catsoulacos P, Politis D and Wampler GL: Antitumor activity of homo-aza-steroidal esters of p-bis (2-chloroethyl)aminophenylacetic acid and p-bis (2-chloroethyl) aminophenyl butyric acid. Cancer Chemother. Pharmacol 7: 129-132, 1983.
5. 5 -homo-aza-steroidal ester in P388 and L1210 murine leukemias. Oncology 39: 59-60, 1982.
6. Catsoulacos P: Activity of 3β-hydroxy-13α-amino-13,17-seco-5α-androstan-17-oic-13,17- lactam-p-bis (2-chloroethyl) aminophenoxylacetate on experimental animal tumor and leukemia systems. Oncology 40: 290-292, 1983
7. Catsoulacos P and Boutis L: Antitumor activity of an homo-azasteroidal ester of p-N,N-bis (2-chloroethyl) aminophenylacetic acid. Cancer Chemother. Rep. 57: 365-367, 1973.
8. Catsoulacos P and Wampler GL: Activity of 3β-hydroxy-13α-amino-13,17-seco-5α-androstan-17-oic-13,17- lactam-p-bis (2-chloroethyl) aminophenylacetate. Oncology 39: 109-112, 1982.
9. Catsoulakos P: Further study on the antineoplastic activity of 3β-hydroxy-13α-amino-13,17-seco-5α-androstan-17-oic-13,17- lactam-p-bis (2-chloroethyl) aminophenylacetate. Cancer Lett 22: 199-202, 1984.
10. Catsoulacos P, Politis D, Boutis L and Papageorgiou A: Antitumor activity of 3β-hydroxy-13α-amino - 13,17 - seco - 5α - androstan - 17 -oic-13,17 -lactam - p - bis (2-chloroethyl) aminophenylbutyrate. J.Pharm. Sciences 67: 1342-1343, 1978.
11. Kleine I and Platonova GN: Experimental Evaluation of Anticancer Drugs in the USA and USSR and Clinical Correlation, Goldin A, Kleine I, Sofina ZP and Syrkin AB: eds, National Cancer Institute Monograph 55, NIH Publication No. 80-193, NCI, Bethesda, Maryland 20205, 1980, p. 25.
12. Goto K, Maeda S, Kano Y and Sugiyama T: Factors involved in differential Giesma-staining of sister chromatids. Chromosoma 66: 351-359, 1978.
13. Tofilon P, Basic I and Milas L: Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro SCE assay. Cancer Res 45: 2025-2030, 1985.
14. Mourelatos D, Dozi-Vassiliades J, Kotsis A and Gourtsas C: Enhancement of cytogenetic damage and of antineoplastic effect in vivo. Cancer Res 48: 1121-1131, 1988.
15. Papageorgiou A, Koliais SI, Antonoglou O, Catsoulacos P and Boutis L: Studies on the effect of homo-aza-steroidal ester of p-bis (2-chloroethyl) aminophenylacetic acid in Ehrich ascites tumor cells. Meth and Find Exptl Clin Pharmacol 6(1): 5-9, 1984.
16. Papageorgiou A, Ivanov I, Markov G, Boutis L and Catsoulacos P: Does ASE form interstrand cross links in the DNA of Ehrlich ascites cells (EAT)? Anticancer Research 4: 9-11, 1984.
17. Morris SM and Heflich RM: A comparition ofthe toxic and SCE-inducing effects of inhibitors of ADP-ribosyl transferase in CHO cells. Mutation Res 126: 63-71, 1984.
18. Mourelatos D: Chromosomes study as predictor of chemoresponse of tumors. The cancer Journal 9: 136-141, 1996.
19. Deen DF, Kentall LE and Marton LG: Prediction oftumor cell chemosensitivity using the SCE assay. Cancer Res. 46: 1599-1602, 1986.